HutchMED (China) LIMITED (HMDCF) Stock buybacks 2016–2025
HutchMED (China) LIMITED (HMDCF) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$36.1MFY2025 · since FY2016: $1.8M → $36.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $36.1M | +297.6% |
| FY2024 | $9.1M | -81.1% |
| FY2023 | $48.1M | +76.1% |
| FY2022 | $27.3M | +111.6% |
| FY2021 | $12.9M | +3629.5% |
| FY2020 | $346,000 | -93.7% |
| FY2019 | $5.5M | +298.8% |
| FY2018 | $1.4M | +126.3% |
| FY2017 | $604,000 | -66.2% |
| FY2016 | $1.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HMDCF financial trends
HMDCF RevenueHMDCF Net incomeHMDCF Net marginHMDCF Gross profitHMDCF Gross marginHMDCF Operating incomeHMDCF Operating marginHMDCF Operating cash flowHMDCF Free cash flowHMDCF Capital expendituresHMDCF Return on equityHMDCF Dividends paidHMDCF Total assetsHMDCF Total liabilitiesHMDCF Shareholders’ equityHMDCF overview →